Ducommun Incorporated
DCO · NYSE
9/27/2025 | 6/28/2025 | 3/29/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 1.40 | 0.38 | -1.04 |
| FCF Yield | 1.14% | 1.41% | -0.47% | 1.54% |
| EV / EBITDA | -17.55 | 55.46 | 44.04 | 62.99 |
| Quality | ||||
| ROIC | -6.65% | 1.42% | 1.34% | 1.07% |
| Gross Margin | 26.57% | 26.57% | 26.58% | 23.52% |
| Cash Conversion Ratio | -0.28 | 1.79 | 0.07 | 2.72 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.30% | 2.27% | 2.65% | 3.35% |
| Free Cash Flow Growth | -11.75% | 548.64% | -127.75% | 21.93% |
| Safety | ||||
| Net Debt / EBITDA | -0.07 | 8.06 | 9.52 | 12.56 |
| Interest Coverage | 27.35 | 5.91 | 5.08 | 2.88 |
| Efficiency | ||||
| Inventory Turnover | 0.81 | 0.73 | 0.72 | 0.77 |
| Cash Conversion Cycle | 109.12 | 223.71 | 226.99 | 213.78 |